Faculty profile

Jessica Mcalpine

ResearcherObstetrics and GynecologyUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Jessica Mcalpine

Researcher

Obstetrics and Gynecology

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
2 publications in the last five years, latest in 2025.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 8 research grants (8 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Molecular Classification Endometrial Cancer De-Escalated Surgery Human Papilloma Virus (Hpv)Molecular Stratification P16 Immunohistochemistry (Ihc)Patient Reported Quality Of Life Personalized Medicine

Latest papers

Molecular Characterization and Clinical Implications of Endometrial Cancer.
Obstetrics and gynecology · 2025 · senior author
Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas.
Histopathology · 2025
Submillimeter diameter rotary-pullback fiber-optic endoscope for narrowband red-green-blue reflectance, optical coherence tomography, and autofluorescence in vivo imaging.
Journal of biomedical optics · 2019

All 10 publications

Latest funding

Biologic basis of contraceptive choice associated ovarian cancer risk: from populations through cells to action
CIHR · 2025 · Co-investigator
$2,000,000
STRIVE Study: STRatIfication of Vulvar squamous cell carcinoma by HPV and p53 status to guide Excision
CIHR · 2024 · Principal investigator
$1,166,628
Endometriosis-associated ovarian cancer: Understanding which patients are at high risk
CIHR · 2023 · Co-investigator
$680,851

All 19 grants and awards

10 publications.

Molecular Characterization and Clinical Implications of Endometrial Cancer.

Secord AA, Powell MA, McAlpine J

Obstetrics and gynecology2025Senior author

DOI: 10.1097/aog.0000000000006080 PMID: 40966692

Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas.

Akbari A, Pors J, Lum A, Leung S, Cochrane D, Jamieson A, McAlpine J, Kommoss S, Huvila J, Huntsman D, Talhouk A, Singh N, Gilks CB, Hoang L

Histopathology2025

DOI: 10.1111/his.15393 PMID: 39687985

Submillimeter diameter rotary-pullback fiber-optic endoscope for narrowband red-green-blue reflectance, optical coherence tomography, and autofluorescence in vivo imaging.

Buenconsejo AL, Hohert G, Manning M, Abouei E, Tingley R, Janzen I, McAlpine J, Miller D, Lee A, Lane P, MacAulay C

Journal of biomedical optics2019

DOI: 10.1117/1.jbo.25.3.032005 PMID: 31650742

OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.

Webber K, Carolus E, Mileshkin L, Sommeijer D, McAlpine J, Bladgen S, Coleman RL, Herzog TJ, Sehouli J, Nasser S, Inci G, Friedlander M

Gynecologic oncology2019

DOI: 10.1016/j.ygyno.2019.08.009 PMID: 31416612

Does MMR status in endometrial cancer influence response to adjuvant therapy?

Kim SR, Pina A, Albert A, McAlpine J, Wolber R, Blake Gilks C, Kwon JS

Gynecologic oncology2018

DOI: 10.1016/j.ygyno.2018.08.020 PMID: 30172479

The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.

McAlpine J, Leon-Castillo A, Bosse T

The Journal of pathology2018First author

DOI: 10.1002/path.5034 PMID: 29344951

Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.

Karnezis AN, Hoang LN, Coatham M, Ravn S, Almadani N, Tessier-Cloutier B, Irving J, Meng B, Li X, Chow C, McAlpine J, Kuo KT, Mao TL, Djordjevic B, Soslow RA, Huntsman DG, Blake Gilks C, Köbel M, Lee CH

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2016

DOI: 10.1038/modpathol.2015.155 PMID: 26743474

Quality of life and patient-reported outcomes in endometrial cancer clinical trials: a call for action!

Joly F, McAlpine J, Nout R, Åvall-Lundqvist E, Shash E, Friedlander M, Gynaecologic Cancer InterGroup (GCIG)

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society2014

DOI: 10.1097/igc.0000000000000299 PMID: 25340294

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.

Kwon JS, Tinker A, Pansegrau G, McAlpine J, Housty M, McCullum M, Gilks CB

Obstetrics and gynecology2013

DOI: 10.1097/aog.0b013e3182783c2f PMID: 23232752

A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer.

Brotto LA, Erskine Y, Carey M, Ehlen T, Finlayson S, Heywood M, Kwon J, McAlpine J, Stuart G, Thomson S, Miller D

Gynecologic oncology2012

DOI: 10.1016/j.ygyno.2012.01.035 PMID: 22293042

Biologic basis of contraceptive choice associated ovarian cancer risk: from populations through cells to action

Co-investigatorCIHR2025Team Grant: Bringing Biology to Cancer Prevention - Cancer in Women

Principal investigators: Huntsman, David G; Cook, Jocelynn L; Hanley, Gillian E; Norman, Wendy V

Keywords: Fallopian Tube Pathophysiology; High-Grade Serous Cancer; Hormonal Contraceptives; Integrated Knowledge Mobilization; Molecular Pathology; Ovarian Cancer¿Prevention; Population-Based Data; Precision Contraception; Risk-Modeling; Shared Decision-Making

$2,000,000

STRIVE Study: STRatIfication of Vulvar squamous cell carcinoma by HPV and p53 status to guide Excision

Principal investigatorCIHR2024Project Grant

Principal investigators: Jamieson, Amy; Mcalpine, Jessica N

Keywords: De-Escalated Surgery; Human Papilloma Virus (Hpv); Molecular Stratification; P16 Immunohistochemistry (Ihc); Patient Reported Quality Of Life; Personalized Medicine; Prospective Clinical Trial; Surgical Margins; Tp53 Mutations/P53 Immunohistochemistry (Ihc); Vulvar Squamous Cell Carcinoma

$1,166,628

Endometriosis-associated ovarian cancer: Understanding which patients are at high risk

Co-investigatorCIHR2023Project Grant

Principal investigators: Hanley, Gillian E; Anglesio, Michael S

Keywords: Endometriosis; Ovarian Cancer

$680,851

Gynecologic Cancer Impact Accelerator

Nominated PICIHR2023Planning and Dissemination Grant - Institute Community Support

Principal investigators: Mcalpine, Jessica N

Keywords: Cancer Care Delivery; Ethnicity; Genetic Testing; Gynecologic Cancer; Health Equity; Knowledge Mobilization; Molecular Classification; Precision Oncology; Prevention; Race

$10,000

Endometriosis and ovarian cancer: Understanding which patients are at high risk for ovarian cancer

Co-investigatorCIHR2022Project Grant - Priority Announcement: Early Detection/Cancer Prevention

Principal investigators: Hanley, Gillian E; Anglesio, Michael S

Keywords: Endometriosis; Ovarian Cancer

$100,000

Improving endometrial cancer risk prediction by including genetic, environmental, and temporal exposures

Co-investigatorCIHR2022Project Grant - PA: Women's Health Research - Early Career Researcher Grant

Principal investigators: Talhouk, Aline

Keywords: Canpath; Canue; Dynamic Risk Models; Endometrial Cancer; Etiology; Gender Role; Precision Prevention; Risk Prediction Modelling; Single Nucleotide Polymorphism; Socio-Economic Factors

$100,000

Canada Research Chair - Tier 1

Nominated PICIHR2021Canada Research Chairs - CIHR Funded - Tier 1

Principal investigators: Mcalpine, Jessica N

Keywords: Crc

$1,400,000

RESToRE – Risk Evaluation and Screening to Tailor prevention and Reduce the incidence of Endometrial cancer

Co-investigatorCIHR2021Operating Grant: CCS/CIHR Action Grants

Principal investigators: Talhouk, Aline

Keywords: Cancer

$100,000

Preventing ovarian cancer through the expansion of opportunistic salpingectomy: Uptake, safety and cost-effectiveness at the time of colorectal surgery

Co-investigatorCIHR2021Operating Grant: CCS/CIHR Action Grants

Principal investigators: Hanley, Gillian E

Keywords: Cancer

$72,615

Personalizing Prevention Strategies in Endometrial Cancer

Co-investigatorCIHR2019Op Gr: Data Analysis Using Existing Databases n Cohorts-Cancer Prevention n Ctrl

Principal investigators: Talhouk, Aline; Kwon, Janice; Tinker, Anna

Keywords: Biostatistics; Endometrial Cancer; Endometrial Hyperplasia; Hormone Therapy; Indigenous Health; Obesity; Prevention; Risk Disparity; Risk Score Prediction; Screening

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Jessica Mcalpine

Research

Latest papers

Latest funding

Molecular Characterization and Clinical Implications of Endometrial Cancer.

Papillary and ductal patterns of mesonephric-like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas.

Submillimeter diameter rotary-pullback fiber-optic endoscope for narrowband red-green-blue reflectance, optical coherence tomography, and autofluorescence in vivo imaging.

OVQUEST - Life after the diagnosis and treatment of ovarian cancer - An international survey of symptoms and concerns in ovarian cancer survivors.

Does MMR status in endometrial cancer influence response to adjuvant therapy?

The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.

Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.

Quality of life and patient-reported outcomes in endometrial cancer clinical trials: a call for action!

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.

A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer.

Biologic basis of contraceptive choice associated ovarian cancer risk: from populations through cells to action

STRIVE Study: STRatIfication of Vulvar squamous cell carcinoma by HPV and p53 status to guide Excision

Endometriosis-associated ovarian cancer: Understanding which patients are at high risk

Gynecologic Cancer Impact Accelerator

Endometriosis and ovarian cancer: Understanding which patients are at high risk for ovarian cancer

Improving endometrial cancer risk prediction by including genetic, environmental, and temporal exposures

Canada Research Chair - Tier 1

RESToRE – Risk Evaluation and Screening to Tailor prevention and Reduce the incidence of Endometrial cancer

Preventing ovarian cancer through the expansion of opportunistic salpingectomy: Uptake, safety and cost-effectiveness at the time of colorectal surgery

Personalizing Prevention Strategies in Endometrial Cancer

Frequent collaborators

Mark Carey

Aline Talhouk

Gavin Stuart

Janice Kwon

Anna Tinker

Basile Tessier-Cloutier

Amy Jamieson

David Huntsman

Calum Macaulay